MEDBASE JOURNEY
From academic roots to clinical excellence
For nearly two decades, we have been on a mission to provide the most reliable scientifically backed drug safety information. Our journey began in 2007 with a clear goal: to equip healthcare professionals with the highest quality information at their fingertips.
Founded by Dr. Kari Laine and Dr. Tuomas Korhonen, Medbase emerged from a mission to tackle the critical issue of drug interactions, which can lead to adverse drug reactions, hospitalisation and even death. Understanding that aging populations and polypharmacy would only intensify these challenges, our founders set out to develop innovative solutions.
‘We knew it wasn’t enough to simply list drug interactions. An information tool must also provide expert advice and recommendations on how to prevent or manage clinical issues,’ says Laine. ‘Moreover, the information needs to be user-friendly and tailored to the local context,’ adds Korhonen.
Their collaboration with Karolinska Institutet and Stockholm County Centre led to the creation of Medbase’s first pharmacological database, focused on drug interactions. This marked the beginning of Medbase’s journey toward transforming drug safety.
Expanding the scope of drug safety
Medbase has since expanded its offerings to include nine additional datasets, each offering critical insights into all relevant areas of drug safety. These advancements have been shaped by the founders’ extensive experience, gathered from thousands of medication consultations with healthcare professionals before Medbase was established. This practical knowledge ensures that Medbase delivers exactly what healthcare professionals seek in their daily practice.
To make this information easily accessible, Medbase offers advanced software solutions that seamlessly integrate into healthcare workflows. Today, Medbase’s drug information is used in over 20 countries, helping hundreds of thousands of healthcare professionals make informed decisions in their everyday work.
Our commitment to patient safety
Our priority is improving drug safety to directly enhance patient health and quality of life. We strive to equip healthcare professionals with the best tools for informed decision-making, ensuring that every patient receives the care they deserve.
Single source for safe drug therapy
A comprehensive set of clinically relevant, evidence-based drug information
For everyday clinical work
Accessible solutions for any healthcare setting, with easy integration
Enhanced patient outcomes
Empowering healthcare professionals with science to deliver the best possible drug therapy
Committed to Quality
Our commitment to quality is at the heart of everything we do, shaping every decision and action we take. We consistently aim for excellence, ensuring that our products and services exceed industry standards and meet the highest expectations of our customers.
Clinical expertise behind our information
All information is created and validated by physicians specialised in pharmacology.
Not too much, not too little. Just right.
We focus on clinically relevant information that is directly applicable to clinical decision-making.
Seamless user experience
The latest technology and user-friendly information lead to high customer satisfaction and strong partnerships.
Comprehensive Quality Management System
Supported by our QMS, we uphold the highest standards in our operations, solutions and people.
Sustainability
For us, sustainability goes beyond environmental stewardship—it is about ethical responsibility and long-term impact. By leveraging cutting-edge technology and fostering a culture of safety, we empower healthcare providers and professionals to make informed decisions that enhance patient outcomes while minimising risks.
Our approach not only prioritises patient safety and efficient healthcare practices but also contributes to the sustainability of the healthcare system.
For media
For all media inquiries or interview requests, please reach out to iina.eshed@medbase.fi. We will connect you with the most suitable spokesperson for your needs.
Newsroom
Discover our latest updates & customer references
Genetic variability affects outcomes of drug therapy
- Interview
- PROF. MIKKO NIEMI
“Our product development is foresighted”
- Our People
- CPO MARKUS JANSÉN
Vaaka Partners to invest in Medbase
- Interview